Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5466-5472

  Turner, Bruce C ^a,d,e   Zhang, Jian ^b   Gumbs, Andrew A ^a   Maher, Mary G ^a   Kaplan, Leni ^a   Carter, Darryl ^a   Glazer, Peter M ^a   Hurst, Helen C ^c   Haffty, Bruce G ^a   Williams, Trevor ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

BINDING SITES; BREAST; BREAST NEOPLASMS; DNA-BINDING PROTEINS; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-2; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; RECEPTORS, GROWTH FACTOR; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032403128     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Benz, C. C., Brandt, B. H., and Zanker, K. S. Gene diagnostics provide new insights into breast cancer prognosis and therapy. Gene (Amst.), 159: 3-7, 1995.
2. Hynes, N. E., and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta, 1198: 165-184, 1994.
3. Steeg, P. S., and Abrams, J. S. Cancer prognostics: past, present and p27. Nat. Med., 3: 152-154, 1997.
4. Stratton, M. R., and Wooster, R. Hereditary predisposition to breast cancer. Curr. Opin. Genet. Dev., 6: 93-97, 1996.
5. Walker, R. A., and Varley, J. M. The molecular pathology of human breast cancer. In: N. R. Lemoine and N. A. Wright (eds.), The Molecular Pathology of Cancer, pp. 31-57. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1993.
6. Chevallier, B., Heintzmann, F., Mosseri, V., Dauce, J. P., Bastit, P., Graic, Y., Brunelle, P., Basuyau, J. P., Comoz, M., and Asselain, B. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis. Cancer (Phila.), 62: 2517-2524, 1988.
7. Haffty, B. G., Brown, F., Carter, D., and Flynn, S. Evaluation of HER-2/neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study. Int. J. Radiat. Oncol. Biol. Phys., 35: 751-757, 1996.
8. McGuire, W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol., 5: 428-433, 1978.
9. King, R. J. B. A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J. Steroid Biochem. Mol. Biol., 39: 811-818, 1991.
10. Bosher, J. M., Williams, T., and Hurst, H. C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA, 92: 744-747, 1995.
11. Bosher, J. M., Totty, N. F., Hsuan, J. J., Williams, T., and Hurst, H. C. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene, 13: 1701-1707, 1996.
12. McPherson, L. A., Baichwal, V. R., and Weigel, R. J. Identification of ERF-1 as a member of the AP-2 transcription factor family. Proc. Natl. Acad. Sci. USA, 94: 4342-4347, 1997.
13. Chazaud, C., Oulad-Abdelghani, M., Bouillet, P., Décimo, D., Chambon, P., and Dollé, P. AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech. Dev., 54: 83-94, 1996.
14. Mitchell, P. J., Timmons, P. M., Hébert, J. M., Rigby, P. W. J., and Tjian, R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev., 5: 105-119, 1991.
15. Moser, M., Imhof, A., Pscherer, A., Bauer, R., Amselgruber, W., Sinowatz, F., Hofstädter, F., Schüle, R., and Buettner, R. Cloning and characterization of a second AP-2 transcription factor: AP-2β. Development (Camb.), 121: 2779-2788, 1995.
16. Schorle, H., Meier, P., Buchert, M., Jaenisch, R., and Mitchell, P. J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature (Lond.), 381: 235-238, 1996.
17. Zhang, J., Hagopian-Donaldson, S., Serbedzija, G., Elsemore, J., Plehn-Dujowich, D., McMahon, A. P., Flavell, R. A., and Williams, T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature (Lond.), 381: 238-241, 1996.
18. Moser, M., Pscherer, A., Roth, C., Becker, J., Mucher, G., Zerres, K., Dixkens, C., Weis, J., Guay-Woodford, L., Buettner, R., and Fassler, R. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev., 11: 1938-1948, 1997.
19. Williams, T., and Tjian, R. Analysis of the DNA binding and activation properties of the human transcription factor AP-2. Genes Dev., 5: 670-682, 1991.
20. deConinck, E. D., McPherson, L. A., and Weigel, R. J. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol. Cell. Biol., 15: 2191-2196, 1995.
21. Creaser, P., D'Argenio, D. A., and Williams, T. Comparative and functional analyses of the AP-2 promoter indicate that conserved octamer and initiator elements are critical for activity. Nucleic Acids Res., 13: 2597-2605, 1996.
22. Turner, B. C., Haffty, B. G., Narayanan, L., Yuan, J., Havre, P. A., Gumbs, A. A., Kaplan, L., Burgaud, J-L., Carter, D., Baserga, R., and Glazer, P. M. Insulin-like growth factor I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res., 57: 3079-3083, 1997.
23. Williams, T., Admon, A., Lüscher, B., and Tjian, R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev., 2: 1557-1569, 1988.
24. King, W. J., DeSombre, E. R., Jensen, E. V., and Greene, G. L. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res., 45: 293-296, 1985.
25. Cooke, D. W., Bankert, L. A., Roberts, C. T. J., LeRoith, D., and Casella, S. J. Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem. Biophys. Res. Commun., 177: 1113-1120, 1991.
26. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
27. Werner, H., Bach, M. A., Stannard, B., Roberts, C. T., and LeRoith, D. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol. Endocrinol., 6: 1545-1558, 1992.
28. Bates, N. P., and Hurst, H. C. Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland. J. Mammary Gland Biol. Neoplasia, 2: 153-163, 1997.
29. Gilbertson, R. J., Perry, R. H., Kelly, P. J., Pearson, A. D. J., and Lunec, J. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res., 57: 3272-3280, 1997.
30. Werner, H., Hernandez-Sanchez, C., Karnieli, E., and LeRoith, D. The regulation of IGF-I receptor gene expression. Int. J. Biochem. Cell Biol., 27: 987-994, 1995.
31. Duan, C., and Clemmons, D. R. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. Biol. Chem., 270: 24844-24851, 1995.
32. Byrne, C. Regulation of gene expression in developing epidermal epithelia. Bioessays, 19: 691-698, 1997.
33. Fini, M. E., Bartlett, J. D., Matsubara, M., Rinehart, W. B., Mody, M. K., Girard, M. T., and Rainville, M. The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP-1 and AP-2 in cell type-specific transcription. J. Biol. Chem., 269: 28620-28628, 1994.
34. Hennig, G., Lowrick, O., Birchmeier, W., and Behrens, J. Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem., 271: 595-602, 1996.
35. Mellentin-Michelotti, J., John, S., Pennie, W. D., Williams, T., and Hager, G. L. The 5′ enhancer of the mouse mammary tumor virus long terminal repeat contains a functional AP-2 element. J. Biol. Chem., 269: 31983-31990, 1994.
36. Mitchell, P. J., Wang, C., and Tjian, R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell, 50: 847-861, 1987.
37. Somasundaram, K., Jayaraman, G., Williams, T., Moran, E., Frisch, S., and Thimmapaya, B. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc. Natl. Acad. Sci. USA, 93: 3088-3093, 1996.
38. waf1/cip1 expression. Nat. Genet., 15: 78-82, 1997.
39. Zutter, M. M., Santoro, S. A., Painter, A. S., Tsung, Y. L., and Gafford, A. The human α2 integrin gene promoter. Identification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression. J. Biol. Chem., 269: 463-469, 1994.
40. Kannan, P., Buettner, R., Chiao, P. J., Yim, S. O., Sarkiss, M., and Tainsky, M. A. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev., 8: 1258-1269, 1994.
41. Califano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56: 2488-2492, 1996.
42. Davies, A. F., Stephens, R. J., Olavesen, M. G., Heather, L., Dixon, M. J., Magee, A., Flinter, F., and Ragoussis, J. Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum. Mol. Genet., 4: 121-128, 1995.
43. Foulkes, W. D., Ragoussis, J., Stamp, G. W. H., Allan, G. J., and Trowsdale, J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer, 67: 551-559, 1993.
44. Randerson, J., Cawkwell, L., Jack, A., Lewis, F., Johnson, P., Evans, P., Barrans, S., and Morgan, G. J. Fluorescent polymerase chain reaction of a panel of CA repeats on chromosome 6 in the indolent phase of follicular centre cell lymphoma. Br. J. Cancer, 74: 942-946, 1996.
45. Muchardt, C., Seeler, J-S., Nirula, A., Gong, S., and Gaynor, R. Transcription factor AP-2 activates gene expression of HTLV-I. EMBO J., 11: 2573-2581, 1992.